Transplantasyon İmmünolojisi: Nakil Reddi Mekanizmaları ve Tedavi Stratejileri
Özet
Referanslar
Abul K. Abbas, Andrew H. Lichtman, & Shiv Pillai. (2020). Transplantation Immunology. In Basic Immunology: Functions and Disorders of the Immune System (6th ed., Chapter 10, pp. 191–212).
Klein, J., & Sato, A. (2000). The HLA system: first of two parts. The New England Journal of Medicine, 343(10), 702-709. doi:10.1056/NEJM200009073431006
Saeed, S., Quintin, J., Kerstens, H. H. D., et al. (2014). Epigenetic programming of monocyte-to-macrophage differentiation and trained innate immunity. Science, 345(6204), 1250684. DOI: 10.1126/science.1251086
Corthay, A. (2004). A three-cell model for activation of naïve T-helper cells. Scandinavian Journal of Immunology, 60(1-2), 93-96. doi: 10.1111/j.1365-3083.2006.01782.x
Reddy, P., & Ferrara, J. L. M. (2003). Pathophysiology of graft-versus-host disease: implications for novel preventative and therapeutic strategies. Nature Reviews Immunology, 3(5), 397–406. https://doi.org/10.1038/nri1084
Shlomchik, W. D. (2007). Graft-versus-host disease. Nature Reviews Immunology, 7(5), 340–352. https://doi.org/10.1038/nri2000
Ferrara, J. L. M., Levine, J. E., Reddy, P., & Holler, E. (2009). Graft-versus-host disease. The Lancet, 373(9674), 1550–1561. https://doi.org/10.1016/S0140-6736(09)60237-3
Spiering, R., & van der Wagen, M. (2020). Mechanistic insights into tolerance induction strategies in transplantation. Nature Reviews Immunology, 20(5), 303–317. https://doi.org/10.1038/s41577-020-0274-6
Zeiser, R., & Blazar, B. R. (2017). Pathophysiology of chronic graft-versus-host disease and therapeutic targets. New England Journal of Medicine, 377(26), 2565–2579. https://doi.org/10.1056/NEJMra1703472
Kitchens, W. H., Chae, O. M., Uehara, S., et al. (2007). Macrophage depletion suppresses cardiac allograft vasculopathy in mice. American Journal of Transplantation, 7(12), 2682-2688. doi.org/10.1111/j.1600-6143.2007.01997.x
Klein, J., & Sato, A. (2000). The HLA system: second of two parts. The New England Journal of Medicine, 343(11), 782-786. doi.org/10.1056/nejm200009143431106
Mickelson, E. M., Fefer, A., Storb, R., & Thomas, E. D. (1976). Correlation of the relative response index with marrow graft rejection in patients with aplastic anemia. Transplantation, 22(4), 294-330.
Spellman, S., Setterholm, M., Maiers, M., Noreen, H., Oudshoorn, M., Fernandez-Viña, M., et al. (2008). Advances in the selection of HLA-compatible donors: refinements in HLA typing and matching over the first 20 years of the National Marrow Donor Program Registry. Biology of Blood and Marrow Transplantation, 14(Suppl 1), 37-44. doi.org/10.1016/j.bbmt.2008.05.001
Zacher, T., van Rooijen, N., Rothstein, D. M., Shlomchik, W. D., & Lakkis, F. G. (2009). An innate response to allogeneic monocytes is mediated by monocytes. American Journal of Transplantation, 9(3), 711-718. doi.org/10.4049/jimmunol.0902194
Zou, Y., & Stastny, P. (2009). The role of major histocompatibility complex class I chain-related gene A antibodies in organ transplantation. Current Opinion in Organ Transplantation, 14(4), 414-418. DOI: 10.1097/MOT.0b013e32832d835e
Kahan, B. D. (1999). Cyclosporine: a revolution in transplantation. Transplantation Proceedings, 31(Suppl 1), 14S-15S.
Marsh, S. G. (2009). WHO nomenclature committee for factors of the HLA system: nomenclature for factors of the HLA system, update. Tissue Antigens, 74(4), 364-366. doi: 10.1111/j.1399-0039.2007.00911.x
Tacke, F., & Zimmermann, H. W. (2014). Macrophage polarization in liver injury and repair. Hepatology, 60(3), 1060-1069. doi.org/10.3389/fmed.2021.814496
Dai, H., Friday, A. J., Abou-Daya, K. I., Williams, A. L., Mortin-Toth, S., Nicotra, M. L., ... & Lakkis, F. G. (2017). Donor SIRPα polymorphism modulates the innate immune response to allogeneic grafts. Science immunology, 2(12), eaam6202. DOI: 10.1126/sciimmunol.aam6202
Kissmeyer-Nielsen, F., Olsen, S., Petersen, V. P., & Fjeldborg, O. (1966). Hyperacute rejection of kidney allografts associated with pre-existing humoral antibodies against donor cells. The Lancet, 288(7465), 662-665. doi.org/10.1016/S0140-6736(66)92829-7
